skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Gronchi, Alessandro ; Palmerini, Emanuela ; Quagliuolo, Vittorio ; Martin Broto, Javier ; Lopez Pousa, Antonio ; Grignani, Giovanni ; Brunello, Antonella ; Blay, Jean-Yves ; Tendero, Oscar ; Diaz Beveridge, Robert ; Ferraresi, Virginia ; Lugowska, Iwona ; Merlo, Domenico Franco ; Fontana, Valeria ; Marchesi, Emanuela ; Braglia, Luca ; Donati, Davide Maria ; Palassini, Elena ; Bianchi, Giuseppe ; Marrari, Andrea ; Morosi, Carlo ; Stacchiotti, Silvia ; Bagué, Silvia ; Coindre, Jean Michel ; Dei Tos, Angelo Paolo ; Picci, Piero ; Bruzzi, Paolo ; Casali, Paolo Giovanni

Journal of clinical oncology, 2020-07, Vol.38 (19), p.2178-2186 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
2
Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control
Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control

BONVALOT, Sylvie ; RIVOIRE, Michel ; CASTAING, Marine ; STOECKLE, Eberhard ; LE CESNE, Axel ; YVES BLAY, Jean ; LAPLANCHE, Agnès

Journal of clinical oncology, 2009-01, Vol.27 (1), p.31-37 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

SLEIJFER, Stefan ; RAY-COQUARD, Isabelle ; VAN GLABBEKE, Martine ; VERWEIJ, Jaap ; BLAY, Jean-Yves ; PAPAI, Zsuzsa ; LE CESNE, Axel ; SCURR, Michelle ; SCHÖFFSKI, Patrick ; COLLIN, Françoise ; PANDITE, Lini ; MARREAUD, Sandrine ; DE BRAUWER, Annick

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3126-3132 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation
Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation

SALAS, Sébastien ; DUFRESNE, Armelle ; OBERLIN, Odile ; BROUSTE, Véronique ; COINDRE, Jean-Michel ; BUI, Binh ; BLAY, Jean-Yves ; TERRIER, Philippe ; RANCHERE-VINCE, Dominique ; BONVALOT, Sylvie ; STOECKLE, Eberhard ; GUILLOU, Louis ; LE CESNE, Axel

Journal of clinical oncology, 2011-09, Vol.29 (26), p.3553-3558 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

Hensley, Martee L ; Enserro, Danielle ; Hatcher, Helen ; Ottevanger, Petronella B ; Krarup-Hansen, Anders ; Blay, Jean-Yves ; Fisher, Cyril ; Moxley, Katherine M ; Lele, Shashikant B ; Lea, Jayanthi S ; Tewari, Krishnansu S ; Thaker, Premal H ; Zivanovic, Oliver ; O'Malley, David M ; Robison, Katina ; Miller, David S

Journal of clinical oncology, 2018-11, Vol.36 (33), p.JCO1800454-3330 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy

DEMETRI, George D ; CHAWLA, Sant P ; REICHARDT, Peter ; BOMPAS, Emmanuelle ; ALCINDOR, Thierry ; RUSHING, Daniel ; YANG SONG ; LEE, Ruey-Min ; EBBINGHAUS, Scot ; EID, Joseph E ; LOEWY, John W ; HALUSKA, Frank G ; RAY-COQUARD, Isabelle ; DODION, Pierre F ; BLAY, Jean-Yves ; LE CESNE, Axel ; STADDON, Arthur P ; MILHEM, Mohammed M ; PENEL, Nicolas ; RIEDEL, Richard F ; BUI-NGUYEN, Binh ; CRANMER, Lee D

Journal of clinical oncology, 2013-07, Vol.31 (19), p.2485-2492 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

PENEL, Nicolas ; BINH NGUYEN BUI ; ISAMBERT, Nicolas ; PEYRADE, Frédéric ; CHEVREAU, Christine ; BOMPAS, Emmanuelle ; BRAIN, Etienne G. C ; BLAY, Jean-Yves ; BAY, Jacques-Olivier ; CUPISSOL, Didier ; RAY-COQUARD, Isabelle ; PIPERNO-NEUMANN, Sophie ; KERBRAT, Pierre ; FOURNIER, Charles ; TAIEB, Sophie ; JIMENEZ, Marta

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5269-5274 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

DEMETRI, George D ; CHAWLA, Sant P ; LEBEDINSKY, Claudia ; ELSAYED, Yusri A ; IZQUIERDO, Miguel A ; GOMEZ, Javier ; PARK, Youn C ; LE CESNE, Axel ; VON MEHREN, Margaret ; RITCH, Paul ; BAKER, Laurence H ; BLAY, Jean Y ; HANDE, Kenneth R ; KEOHAN, Mary L ; SAMUELS, Brian L ; SCHUETZE, Scott

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4188-4196 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

CHAWLA, Sant P ; STADDON, Arthur P ; RIVERA, Victor M ; CLACKSON, Tim ; LOEWY, John W ; HALUSKA, Frank G ; DEMETRI, George D ; BAKER, Laurence H ; SCHUETZE, Scott M ; TOLCHER, Anthony W ; D'AMATO, Gina Z ; BLAY, Jean-Yves ; MITA, Monica M ; SANKHALA, Kamalesh K ; BERK, Lori

Journal of clinical oncology, 2012-01, Vol.30 (1), p.78-84 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels

Casali, Paolo G ; Zalcberg, John ; Le Cesne, Axel ; Reichardt, Peter ; Blay, Jean-Yves ; Lindner, Lars H ; Judson, Ian R ; Schöffski, Patrick ; Leyvraz, Serge ; Italiano, Antoine ; Grünwald, Viktor ; Pousa, Antonio Lopez ; Kotasek, Dusan ; Sleijfer, Stefan ; Kerst, Jan M ; Rutkowski, Piotr ; Fumagalli, Elena ; Hogendoorn, Pancras ; Litière, Saskia ; Marreaud, Sandrine ; van der Graaf, Winette ; Gronchi, Alessandro ; Verweij, Jaap

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1713-1720 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (287)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.